Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Retargeting of Citokine-Induced Killer (CIK) Cells with Molecularly Engrafted T-Cell Receptors (TCR): A Preclinical in Vitro and In Vivo Study

Angela Rita Elia, Giorgio Inghirami, Paola Circosta, Flavio Cristofani, Nathalie Santoro, Dario Sangiolo, Corrado Tarella, MD, Alessandro Cignetti

Blood (2011) 118 (21): 1917.

https://doi.org/10.1182/blood.V118.21.1917.1917

Published: 2011

Journal Articles

MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.

Dario Sangiolo, MD, PhD, Giorgio Valabrega, MD, Giuliana Cavalloni, PhD, Sonia Capellero, Giulia Mesiano, Maja Todorovic, Cristina Cammarata, Caterina Peraldo Neia, Wanda Piacibello, MD, Alessandro Cignetti, MD, PhD, Massimo Aglietta, MD

Blood (2009) 114 (22): 4092.

https://doi.org/10.1182/blood.V114.22.4092.4092

Published: 2009

Journal Articles

Lentiviral Engineered T Regulatory Cells Effectively Inhibit Lymphocytes Alloreactivity across Major HLA Barriers

Dario Sangiolo, MD, Noela Jordaney, Giulia Mesiano, Paola Circosta, Angela Elia, Stefania Stella, Maja Todorovic, Fabrizio Carnevale-Schianca, Massimo Aglietta, Alessandro Cignetti

Blood (2008) 112 (11): 3515.

https://doi.org/10.1182/blood.V112.11.3515.3515

Published: 2008

Journal Articles

Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Severe Aplastic Anemia (SAA) above the Age of 40 Years.

Dario Sangiolo, MD, Rainer Storb, MD, Wendy Leisenring, George Georges, MD

Blood (2006) 108 (11): 3019.

https://doi.org/10.1182/blood.V108.11.3019.3019

Published: 2006

Journal Articles

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD

Blood (2006) 107 (9): 3795–3803.

https://doi.org/10.1182/blood-2005-10-3945

Published: 2006

Journal Articles

Expanded Human NKT Type II Cells: Effective Against Colon Cancer Cells, Safe across Major MHC Barriers and Successfully Expandable after Non-Myeloablative HCT for Solid Tumors.

Dario Sangiolo, MD, Emanuela Martinuzzi, Fabrizio Carnevale-Schianca, MD, Antonio Capaldi, MD, Massimo Geuna, PhD, Katiuscia Vitaggio, Massimo Aglietta, MD, Alessandro Cignetti, MD, PhD

Blood (2005) 106 (11): 5239.

https://doi.org/10.1182/blood.V106.11.5239.5239

Published: 2005

Journal Articles

Oncoretroviral and Lentiviral Transduction of Donor T Cells to Facilitate Engraftment of Dog Leukocyte Antigen (DLA)-Haploidentical T-Cell-Depleted Marrow.

Dario Sangiolo, M.D., Marina Lesnikova, Ph.D., Alla Nikitine, M.D., Hans-Peter Kiem, M.D., Rainer Storb, M.D., Richard A. Nash, M.D., George E. Georges, M.D.

Blood (2004) 104 (11): 1751.

https://doi.org/10.1182/blood.V104.11.1751.1751

Published: 2004

NARROW

Retargeting of Citokine-Induced Killer (CIK) Cells with Molecularly Engrafted T-Cell Receptors (TCR): A Preclinical in Vitro and In Vivo Study

MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.

Lentiviral Engineered T Regulatory Cells Effectively Inhibit Lymphocytes Alloreactivity across Major HLA Barriers

Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Severe Aplastic Anemia (SAA) above the Age of 40 Years.

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD

Expanded Human NKT Type II Cells: Effective Against Colon Cancer Cells, Safe across Major MHC Barriers and Successfully Expandable after Non-Myeloablative HCT for Solid Tumors.

Oncoretroviral and Lentiviral Transduction of Donor T Cells to Facilitate Engraftment of Dog Leukocyte Antigen (DLA)-Haploidentical T-Cell-Depleted Marrow.

Email alerts

ASH Publications

American Society of Hematology

Retargeting of Citokine-Induced Killer (CIK) Cells with Molecularly Engrafted T-Cell Receptors (TCR): A Preclinical in Vitro and In Vivo Study

MIC A/B Protein Expression Associates with Trastuzumab-Resistant Breast Cancer Cells Leading to Effective Immunotherapy by Cytokine Induced Killer Cells.

Lentiviral Engineered T Regulatory Cells Effectively Inhibit Lymphocytes Alloreactivity across Major HLA Barriers

Outcome of Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Severe Aplastic Anemia (SAA) above the Age of 40 Years.

Allogeneic nonmyeloablative hematopoietic cell transplantation in metastatic colon cancer: tumor-specific T cells directed to a tumor-associated antigen are generated in vivo during GVHD

Expanded Human NKT Type II Cells: Effective Against Colon Cancer Cells, Safe across Major MHC Barriers and Successfully Expandable after Non-Myeloablative HCT for Solid Tumors.

Oncoretroviral and Lentiviral Transduction of Donor T Cells to Facilitate Engraftment of Dog Leukocyte Antigen (DLA)-Haploidentical T-Cell-Depleted Marrow.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only